Archive for Verastem
Verastem Oncology Outlines Strategic Priorities for 2019 and Highlights Recent Progress
Verastem Oncology Reports Third Quarter 2018 Financial Results
Verastem Oncology Announces Presentation of Preclinical Data Supporting Dual PI3K-delta and PI3K-gamma Inhibition in Combination with Immunotherapy
Verastem Wins FDA Approval for Blood Cancer Drug
Needham-based Verastem Oncology won its first drug approval Monday, a medicine that treats three forms of blood cancer.